VEPESID
Identification of Vepesid
No description |
Google image searchProduct monograph
Active ingredient
etoposide, 50 MG
DIN: 00616192
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: CHEPLAPHARM ARZNEIMITTEL GMBH
Date: 02-JAN-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01C — PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS (ATC, ATC/DDD)
- L01CB — Podophyllotoxin derivatives (ATC, ATC/DDD)
- L01CB01 — ETOPOSIDE (ATC/DDD)
Reference brand drug: Vepesid